tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
PremiumCompany AnnouncementsBright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
2M ago
Bright Minds announces speakers for Absence epilepsy R&D Day
Premium
The Fly
Bright Minds announces speakers for Absence epilepsy R&D Day
2M ago
VA secretary wants to find answers on psychedelics therapies, Politico says
Premium
The Fly
VA secretary wants to find answers on psychedelics therapies, Politico says
3M ago
Bright Minds initiated with a Buy at TD Cowen
PremiumThe FlyBright Minds initiated with a Buy at TD Cowen
3M ago
Bright Minds Biosciences’ BMB-101: A Promising Anti-Seizure Drug with Billion-Dollar Market Potential
Premium
Ratings
Bright Minds Biosciences’ BMB-101: A Promising Anti-Seizure Drug with Billion-Dollar Market Potential
3M ago
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
Premium
The Fly
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
3M ago
Bright Minds Biosciences expands Scientific Advisory Board
PremiumThe FlyBright Minds Biosciences expands Scientific Advisory Board
5M ago
Bright Minds Biosciences to Engage in Key Healthcare Conferences
Premium
Company Announcements
Bright Minds Biosciences to Engage in Key Healthcare Conferences
5M ago
Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential
Premium
Ratings
Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100